BACKGROUND: Fibrolamellar hepatocellular carcinoma (FLC) is a rare primary liver tumor
presenting earlier in life than nonfibrolamellar hepatocellular carcinoma (NFL-HCC), with …

OBJECTIVE. Hepatocellular carcinomas (HCCs) that arise in noncirrhotic livers have several
histologic and biochemical features that distinguish them from HCCs occurring in the setting …

Objective The aims of this study were to determine the prevalence of risk factors associated
with hepatocellular carcinoma (HCC) in black adult South Africans and to estimate the size …

Background Noncirrhotic hepatocellular carcinoma (HCC) is rare. The aim of this study was
to evaluate the published evidence for hepatectomy in patients with noncirrhotic HCC …

Long-term overall survival (OS) after liver resection for non-cirrhotic hepatocellular
carcinoma (NCHCC) has been reported recently. The aim of this study was to review …

BACKGROUND: Emerging data suggest that the fibrolamellar variant of hepatocellular
carcinoma (FL-HCC) differs in clinical course and prognosis from conventional …

Background and Objectives To analyze overall survival (OS) rates for the three curative
treatments of hepatocellular carcinoma (HCC) on an intention‐to‐treat (ITT) basis. Methods …

Abstract Background In South Africa (SA), liver cancer (LC) is a public health problem and
information is limited. Methods Joinpoint regression analysis was computed for the most …

Background Hepatocellular carcinoma (HCC) is a leading cause of mortality in sub-Saharan
Africa (SSA). This systematic review aimed to appraise all population-based studies …

Hepatocellular carcinoma has become a leading cause of cancer-associated mortality
throughout the world, and is of great concern. Currently used chemotherapeutic drugs in the …